Back to search

Article

Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future Perspectives.

2021-08-02

Abstract excerpt

<h4>Background: </h4> Ovarian cancer (OC) represents the eighth most common cancer and the fifth leading cause of cancer-related deaths among the female population. In the advanced setting, chemotherapy represents the first-choice treatment, despite a high recurrence rate. In the last ten years, immunotherapy based on immune checkpoint inhibitors (ICIs) has profoundly modified the therapeutic scenario of many soli...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
73a4d210-58cb-5231-86cd-fd40d51d0c03
DOI
10.20944/preprints202108.0037.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future Perspectives.DOI 10.20944/preprints202108.0037.v1
Select a neighboring publication to make it the new centre.